AI Healthcare ExerChain Selected for US 'Generator' Accelerator Program

## AI Healthcare Innovation Company Exerchain Accelerates Entry into North American Market with US gBETA Selection AI-based healthcare innovation startup Exerchain has been finally selected for the gBETA program, operated by the prestigious US startup accelerator gener8tor, securing a strong foothold for its entry into the North American market. Through this selection, Exerchain has proven its growth potential on the global stage and plans to accelerate its expansion into overseas markets. Exerchain will participate in a three-month intensive program from September 25th to December 12th, held at the WCTC Applied AI Lab in Wisconsin, USA. During this period, Exerchain will have the opportunity to engage directly with leading local venture capitalists (VCs) and top industry experts in the US, thereby refining its business model and expanding its global network. This is expected to play a decisive role in understanding the characteristics of the North American market and meticulously formulating local business strategies. gener8tor, which operates the gBETA program, is a reputable startup accelerator that has successfully supported over 1,000 startups across more than 40 regions in the US and has facilitated over $1.3 billion (approx. 1.7 trillion KRW) in investments. Notably, it was recognized by TechCrunch as "the largest but least-known US accelerator," and recently re-demonstrated its stature and capabilities by ranking 21st in Appwrite's 'Top 30 US Startup Accelerators for 2025'. Exerchain's selection is highly significant as it signifies recognition of its technological prowess and innovative business model by such an authoritative institution. Even before this gBETA selection, Exerchain had already established a solid presence in the global market. It was recognized for its innovation by being selected for 'Project We Love' on the US crowdfunding platform Kickstarter, and achieved the remarkable feat of officially entering Best Buy, a major retail channel in Canada. Furthermore, it has demonstrated its capabilities by achieving successful results in diverse overseas market penetration, including signing a master distribution agreement with JMVN in Vietnam. An Exerchain official stated, "Taking this gBETA program participation as an opportunity, we will maximize our scalability in the North American market and focus all our capabilities on firmly securing a global investor network." The growth trend of the digital health market, which Exerchain focuses on, is very encouraging. According to market research firm Grand View Research, the global digital health market size is projected to more than triple, rapidly growing from approximately $288.5 billion (approx. 380 trillion KRW) in 2024 to $946 billion (approx. 1,250 trillion KRW) by 2030. Particularly, the weight management and wellness sector continues to grow at an annual rate of over double digits, with a surging demand for innovative healthcare solutions based on AI and data. Amidst these market trends, Exerchain is striving for differentiation by leveraging its unique strength: a 'prediction-based healthcare platform'. Building on this gBETA selection, it plans to further accelerate its expansion strategy in line with global market growth and establish itself as a leading company in the digital healthcare sector.